imiquimod has been researched along with Carcinoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y; Zhu, P | 1 |
| Brian Jiang, SI; Hamman, MS | 1 |
| Gilaberte, Y; González, S; Gracia-Cazaña, T | 1 |
| Barysch, MJ; Dummer, R; Kamarashev, J; Lockwood, LL | 1 |
| Ghafouri-Fard, S | 1 |
| Conant, M; Marini, M; Tyring, S; Van Der Meijden, W; Washenik, K | 1 |
| Aubin, F; Drobacheff-Thiebaut, C; Laurent, R; Mougin, C; Pelletier, F; Venier, AG | 1 |
| Costa, RR; de Freitas, VG; de Góis, NM; Kesselring, F; Kobata, MP; Ribalta, JC; Taha, NS | 1 |
| Dirschka, T; Krahl, D; Oster-Schmidt, C | 1 |
| Hwang, D; Kawamoto, H; Liu, H; Scherr, DS; Schwartz, M; Smith, EB; You, X | 1 |
4 review(s) available for imiquimod and Carcinoma
| Article | Year |
|---|---|
Management of trichilemmal carcinoma: an update and comprehensive review of the literature.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma; Hair Follicle; Humans; Imiquimod; Male; Mohs Surgery; Skin Neoplasms | 2014 |
Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antigen-Presenting Cells; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Dermatologic Agents; Diclofenac; Diterpenes; Drug Resistance, Neoplasm; Fluorouracil; Humans; Imiquimod; Meta-Analysis as Topic; Neoplasm Proteins; Neoplastic Stem Cells; Skin Neoplasms | 2016 |
Immunotherapy in nonmelanoma skin cancer.
Topics: Aminoquinolines; Animals; Antibodies, Monoclonal; Cancer Vaccines; Carcinoma; Cytokines; Humans; Imiquimod; Immunologic Factors; Immunotherapy; Skin Neoplasms; T-Lymphocytes | 2012 |
Imiquimod; an international update on therapeutic uses in dermatology.
Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma; Condylomata Acuminata; Dermatologic Agents; DNA Virus Infections; Humans; Imiquimod; Immunocompromised Host; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms | 2002 |
1 trial(s) available for imiquimod and Carcinoma
| Article | Year |
|---|---|
[Effects of imiquimod on latent human papillomavirus anal infection in HIV-infected patients].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminoquinolines; Anus Diseases; Anus Neoplasms; Carcinoma; Double-Blind Method; Female; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Papillomavirus Infections; Prospective Studies; Risk Factors | 2004 |
5 other study(ies) available for imiquimod and Carcinoma
| Article | Year |
|---|---|
Multiple keratoacanthomas in a patient with myelodysplastic syndrome.
Topics: Aclarubicin; Administration, Topical; Antineoplastic Agents; Azacitidine; Carcinoma; Female; Humans; Imiquimod; Keratoacanthoma; Middle Aged; Myelodysplastic Syndromes | 2021 |
Successful treatment of multiple keratoacanthoma with topical imiquimod and low-dose acitretin.
Topics: Acitretin; Administration, Oral; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratolytic Agents; Skin Neoplasms | 2011 |
Grade 3 vulvar and anal intraepithelial neoplasia in a HIV seropositive child--therapeutic result: case report.
Topics: Administration, Topical; Aminoquinolines; Anti-HIV Agents; Anus Neoplasms; Carcinoma; Child; Combined Modality Therapy; Female; Follow-Up Studies; HIV Infections; HIV Seropositivity; Humans; Imiquimod; Immunocompromised Host; Low-Level Light Therapy; Papillomavirus Infections; Risk Assessment; Treatment Outcome; Vulvar Neoplasms | 2005 |
[Multifocal penile intraepithelial neoplasia--targeted treatment with imiquimod].
Topics: Administration, Topical; Aged; Aminoquinolines; Carcinoma; Dermatologic Agents; Drug Delivery Systems; Humans; Imiquimod; Male; Penile Neoplasms; Skin Neoplasms; Treatment Outcome | 2006 |
Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder.
Topics: Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Cytokines; Disease Models, Animal; Humans; Imiquimod; Mice; Toll-Like Receptor 7; Urinary Bladder Neoplasms | 2007 |